<?xml version="1.0" encoding="UTF-8"?>
<p id="p0040">In summary, because of the nature of COVID-19 and the global emergency, many ongoing clinical studies are of suboptimal quality [
 <xref rid="bb0005" ref-type="bibr">1</xref>]. Prospective meta-analysis can serve as an innovative solution to generate reliable data for guiding clinical management and regulatory decision-making [
 <xref rid="bb0045" ref-type="bibr">9</xref>]. However, the success of this approach requires deep understanding of the principle and methodology of the prospective meta-analysis, significant efforts to organize the consortium, and the solidarity that individual investigators will be willing to share their own data.
</p>
